©DANIEL ROUSSELOT/Sanofi

Sanofi To Help Manufacture Moderna COVID-19 Vaccine, Supporting Global Supply Demands

Originally published at sanofi.com. Sanofi U.S. ranked No. 28 on The DiversityInc Top 50 Companies for Diversity list in 2020.

 

Sanofi has entered into an agreement with Moderna, under which Sanofi will help manufacture Moderna´s COVID-19 vaccine, supporting the COVID-19 pandemic and vaccine supply needs.

Sanofi will leverage its established infrastructure and manufacturing expertise at its site in Ridgefield, NJ, to perform fill and finish of up to 200 million doses of Moderna’s COVID-19 vaccine, starting in September 2021.

“Since the beginning of the pandemic, we have been mobilizing on multiple fronts and we showed solidarity across the industry”, said Paul Hudson, Chief Executive Officer, Sanofi. “We are one of the few pharmaceutical companies to leverage many industrial partnerships to improve global supply and access to COVID-19 vaccines, while in parallel, also continuing to develop our two COVID-19 vaccine programs. I would also like to acknowledge the contributions of the Department of Health and Human Services, and the Biden administration, to facilitate this new partnership. ”

This marks Sanofi’s third commitment to provide manufacturing support. Earlier this year, Sanofi announced the company will provide support to BioNTech for 125 million doses for the European Union. In February, Sanofi announced one of its manufacturing site in France would support Johnson & Johnson for the production of its COVID-19 vaccine at a rate of approximately 12 million doses per month. Sanofi is the only large manufacturer to support all three vaccine efforts.

Sanofi continues to be actively involved in discussions with governments and organizations to identify additional areas of pandemic response where the company can make a meaningful impact.

Sanofi continues to prioritize the development of its two COVID-19 vaccine candidates

  • Sanofi is collaborating with GSK on a COVID-19 vaccine candidate using the same recombinant protein-based manufacturing technology as one of Sanofi’s seasonal influenza vaccines, combined with GSK’s established pandemic adjuvant platform.

On February 22, 2021, Sanofi and GSK announced the beginning of a new Phase 2 study with an improved antigen formulation. Enrollment of total 720 participants was completed on March 8 and results are expected in Q2 2021. This vaccine is anticipated to be available in Q4 2021 pending Phase 3 outcomes and regulatory authorizations.

This effort is supported by the United States’ Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response under contract W15QKN-16-9-1002.

  • In addition to the recombinant protein-based vaccine in collaboration with GSK, Sanofi is developing a messenger RNA vaccine in partnership with Translate Bio. In March 2021, Sanofi and Translate Bio initiated a Phase 1/2 clinical trial of their mRNA COVID-19 vaccine candidate, in order to assess safety, immune response and reactogenicity, after preclinical data showed high neutralizing antibody levels.

Find out more about our COVID-19 vaccine candidates.

Latest News

ACLU logo on phone

Second Employee Sues ACLU for Racist and Discriminatory Internal Behavior 

While there’s no disputing the valuable work the American Civil Liberties Union does, from promoting social justice and reform to fighting racism and defending LGBTQ rights, mounting evidence suggests that even one of America’s leading nonprofits dedicated to defending civil rights may have its own internal struggles with systemic racism…

Jane Austen

Newly Unearthed Research Links Beloved Author Jane Austen With England’s Early Abolitionist Anti-Slave Movement

Fans of classic author Jane Austen and her novels, including Emma and Pride and Prejudice, have a new reason to celebrate her life and work. An Arizona State researcher has uncovered previously unknown information linking Austen and her family to England’s anti-slave movement in the early 1800s. Lynn Elber of…

Riz Ahmed

Academy Award-Nominated Actor Riz Ahmed Backs Groundbreaking Study on Muslim Representation in Hollywood 

Earlier this year, British-Pakistani actor Riz Ahmed earned an Oscar nomination for his role in Sound of Metal, an inclusive story about a hearing-impaired musician. Now, the Primetime Emmy Award winner is turning his attention to another vitally important form of representation: positive Muslim depictions in modern Hollywood films. CNN’s…

tractor in field

White Farmers Sue To Stop Debt Relief Program for Farmers of Color

A federal judge in Wisconsin has temporarily halted a government program designed to help chronically disadvantaged farmers of color repay their loans — or forgive their debt altogether. Laura Schulte of the Milwaukee Journal Sentinel reported that “a temporary restraining order was handed down Thursday afternoon [June 10] by Judge…